Tolerability of anastrozole (A) compared with tamoxifen (T): Mature data in the adjuvant setting - Data reported on behalf of the ATAC ('arimidex', tamoxifen, alone or in combination) trialists' group

被引：0

作者：

Mansel, Robert ^{[1
]}

机构：

[1] Univ Wales Hosp, Dept Surg, Cardiff, Wales

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：94 / 94

页数：1

共 50 条

[11] Efficacy data from the ATAC ("arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment
不详
BREAST, 2005, 14 : S51 - S51
[12] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women:: a sub-protocol of the 'Arimidex™ and Tamoxifen Alone or in Combination' (ATAC) trial
Baum, M
Dowsett, M
Coibion, M
Bianco, AR
Cuzick, J
George, WD
Gray, J
Howell, A
Houghton, J
Williams, N
Sloane, J
Tobias, J
Buzdar, A
Anderson, MD
Jackson, I
Sahmoud, T
Gallagher, J
Webster, A
Gangji, D
Petrakova, K
Konopasek, B
Mares, P
Vodvarka, P
Alcazar, A
Campos, O
Maxwell, A
Goedhals
Hacking, D
Landers, G
Smith, L
Vorobiof, DA
Werner, ID
Blamey, R
Coleman, R
Grieve, RJ
Hickish, T
Howell, A
Nicholls, JC
Nicholson, S
Raymond, S
Salman, A
Blum, J
Clark, R
Lyss, A
Miletello, G
Sternberg, J
Forbes, J
Coibion, M
Nabholtz, JM
Guastalla, JP
BRITISH JOURNAL OF CANCER, 2001, 85 (03) : 317 - 324
[13] Effect of anastrozole on bone density and bone turnover: Results of the 'Arimidex' (anastrozole), tamoxifen, alone or in combination (ATAC) study.
Eastell, R
Hannon, RA
Cuzick, J
Clack, G
Adams, JE
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S165 - S165
[14] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial
British Journal of Cancer, 2001, 85 : 317 - 324
[15] Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer
Houghton, J
Baum, M
EUROPEAN JOURNAL OF CANCER, 1998, 34 : S83 - S83
[16] Anastrozole is superior to tamoxifen in the treatment of postmenopausal women with early breast cancer - first results of the ATAC ('Arimidex', Tamoxifen, alone or in combination) trial
Sainsbury, R
INTERNATIONAL JOURNAL OF CANCER, 2002, : 137 - 137
[17] Initial adjuvant therapy with anastrozole - early- and late-event data from the arimidex, tamoxifen, alone or in combination (ATAC) trial in the hormone-responsive population
Howell, A.
Forbes, J.
Cuzick, J.
BREAST, 2009, 18 : S51 - S51
[18] Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer - Results of the ATAC (arimidex, tamoxifen alone or in comhination) trial efficacy and safety update analyses
CANCER, 2003, 98 (09) : 1802 - 1810
[19] The ATAC ('Arimidex' Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal (PMI) women
Tobias, JS
EUROPEAN JOURNAL OF CANCER, 2002, 38 : S92 - S92
[20] Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer
Baum, M
Houghton, J
EUROPEAN JOURNAL OF CANCER, 1998, 34 : S39 - S39

← 1 2 3 4 5 →